Conmed Raises FY18 Financial Guidance - Quick Facts

(RTTNews) - Conmed Corp. (CNMD) announced the company now forecasts full-year 2018 adjusted diluted net earnings per share in the range of $2.15 to $2.20, compared to the previous range of $2.11 to $2.17. This represents growth over 2017 of approximately 14% to 16%.

The company now expects full-year 2018 constant-currency sales growth in the range of 4.5% to 5.5%, compared to the previous range of 4.0% to 5.0%. Based on recent exchange rates, the positive impact to 2018 sales from foreign exchange is anticipated to be between 100 and 150 basis points, which is consistent with the company's previously issued guidance.

First-quarter adjusted diluted net earnings per share were $0.53 versus $0.38 in the prior-year period, an increase of 39.5%. Sales were $202.1 million, up 8.3% year over year as reported and 6.8% in constant currency and as adjusted.